AstraZeneca gets CDSCO Panel nod to market anticancer drug Acalabrutinib Susmita Roy3 Dec 2022 6:00 PM ISTNew Delhi: In a significant development, granting the proposal presented by drug major AstraZeneca Pharma India, the Subject Expert Committee (SEC)...
CDSCO approves AstraZeneca Anticancer Drug Trastuzumab Deruxtecan Protocol Amendment Dr. Divya Colin21 Aug 2022 2:00 PM ISTNew Delhi: Based on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug...
Drug-makers to add Candidiasis as adverse event in Patient Information Leaflet of anticancer drug Docetaxal: CDSCO Panel Susmita Roy5 Jun 2022 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
AstraZeneca gets CDSCO panel nod to study anticancer drug Durvalumab Dr. Divya Colin3 Jun 2022 7:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Labcorp gets CDSCO nod to conduct a study on anticancer drug Dr. Divya Colin20 March 2022 11:15 AM ISTNew Delhi: In a significant development, Labcorp, a leading global life sciences company, has received approval from the Central Drugs Standard...
Novartis Healthcare gets CDSCO panel nod to market anti cancer drug Dabrafenib Susmita Roy19 Feb 2022 5:49 PM ISTNew Delhi: In a significant development, pharmaceutical major Novartis Healthcare has got a go ahead from the Subject Expert Committee (SEC) of the...
Health Bulletin 22/November/2021 Roshni Dhar22 Nov 2021 5:51 PM ISTHere are Top Health stories of the dayPatient dies of Hemorrhagic shock post LSCS: Consumer Court holds medical negligence by doctor, hospital,...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
